PapersPMID:37404567
Effects of Bifidobacterium longum CLA8013 on bowel movement improvement: a placebo-controlled, randomized, double-blind study.
What moved
1 findingHow to read these marks →- Increases stool frequency
moderate
“The primary endpoint, change in defecation frequency, was significantly increased in the treatment group compared with that in the control group after 2 weeks of B. longum CLA8013 consumption (p=0.048), with an increase of 1.16 ± 1.93 times/week.”
- Study
- RCT
- Duration
- 14 days
- Interests
- Industry funded
- Dose studied
- one capsule per day after dinner, 25 billion CFU, oral, 2 weeks
- Population
- Healthy adults aged 20-65 prone to constipation (3-5 spontaneous bowel movements per week, mean Bristol Stool Form Scale below 4); per-protocol set of 104
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- constipation-prone healthy adults
- Participants
- 120
- Comparator
- placebo
- Duration
- 14 days
- Endpoints measured
- 44